ABSTRACT
Background Seroprevalence studies are known to provide better estimates of the proportion of people previously infected, which did not undertake diagnostic testing. Repeated cross-sectional sero-studies are encouraged in the same locations to monitor trends overtime. The aim of this study was to assess the seroprevalence among a random sample of vaccinated and non-vaccinated Palestinian adults living in the West Bank region of Palestine, irrespective of the source of antibodies, be it due to infection with COVID-19 or due to vaccination or both.
Methods This repeated cross-sectional study used serologic testing on a random sample of vaccinated and non-vaccinated adults, 18 years and older residing in 11 governorates of the West Bank region of Palestine. Antibodies/Blood samples were taken using Elecsys Anti-SARS-CoV-2 assay by using the Cobas Analyzer cobas e 411 (Roche) for detection of antibody seropositivity against COVID-19. Seroprevalence was estimated as the proportion of individuals who had a positive result in the total SARS-CoV-2 antibodies in the immunoassay. Sociodemographic information and medical history data was collected using a questionnaire.
Results Among 1451 total participants enrolled in the study, serum samples were tested from 910 persons. Study findings from this randomly selected sample indicated a seroprevalence 75.9%, 95% CI (73.1-78.7). The seroprevalence results indicated that the prevalence of antibodies among those who reported that they were not infected and did not get vaccinated was 45.2% with 95% CI (39.9-50.5%).
The average age of participants was 37.6 years old. 49.2% were female and 50.8% were male. In relation to COVID-19, the following was found:
Conclusion Our findings revealed a drastic rise in seroprevalence of SARS-CoV-2 antibodies. This information is useful for assessing the degree of herd immunity, and provides for better understanding of the pandemic. Population-based seroprevalence studies should be conducted periodically to monitor the SARS-CoV-2 seroprevalence in Palestine and inform policymakers about the efficacy of the surveillance system.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Arab American University of Palestine (www.aaup.edu)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data collection was conducted by healthcare professionals at Arab American University of Palestine following standardized health protocols (World Health, 2020). Approval from the National Ethical Committee was obtained (PHRC/HC/737/20). Written informed consent was obtained from all participants before the interview and the blood sampling and approval of utilization of tests was obtained from Medicare laboratories Participation was completely voluntary and all participants were informed that all the information collected would be anonymous and treated as confidential.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
